Tumor variants in high-risk genes such as BRCA1/2, PALB2, and Lynch syndrome genes (MLH1, MSH2, MSH2, and PMS2) are germline in a significant fraction of cases among unselected and cancer-specific approaches. This evidence concerns the gene BRCA1 and neoplasm.